Concise Review: The Role of Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia
Authors:
- 24 July 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 30 (8) , 1581-1586
Abstract
Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative option for patients with acute myeloid leukemia (AML). Our understanding of the biology of leukemic stem cells has continued to improve over the last decade and risk stratification using cytogenetics and molecular markers have improved our ability to select patients who would benefit from allogeneic transplantation. Results of HSCT have also improved substantitally, extending the potential application of allogeneic transplant to more patients. This review discusses the theoretical aspects of transplant, analyzes clinical results, and provides recommendations for the use of HSCT in AML. Further study of the biology of leukemic stem cells and the role for HSCT is necessary to optimize outcomes in AML patients. STEM CELLS2012;30:1581–1586Keywords
This publication has 56 references indexed in Scilit:
- A clinically relevant population of leukemic CD34+CD38− cells in acute myeloid leukemiaBlood, 2012
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingNature, 2012
- The EBMT activity survey 2009: trends over the past 5 yearsBone Marrow Transplantation, 2011
- Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationNew England Journal of Medicine, 2010
- Hematopoietic Stem-Cell TransplantationNew England Journal of Medicine, 2006
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remissionLeukemia Research, 2004
- Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem CellScience, 1996
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- METHOTREXATE REGIMENS FOR CONTROL OF GRAFT-VERSUS-HOST DISEASE IN DOGS WITH ALLOGENEIC MARROW GRAFTSTransplantation, 1970